C21.1
BillableMalignant neoplasm of anal canal
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is C21.1 an HCC code?
Yes. C21.1 maps to Bladder, Colorectal, and Other Cancers under the CMS-HCC V28 risk adjustment model (and Colorectal, Bladder, and Other Cancers under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C21.1
For C21.1to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C21.1 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
C21.1 is the ICD-10-CM diagnosis code for malignant neoplasm of anal canal. Cancer that develops in the anal canal, which is the short passage that connects the rectum to the external opening of the anus. C21.1 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of digestive organs (c15-c26).
Under the CMS-HCC V28 risk adjustment model, C21.1 maps to Bladder, Colorectal, and Other Cancers (HCC 22) with a community, non-dual, aged base RAF weight of 0.363. Under the older CMS-HCC V24 model, C21.1 maps to Colorectal, Bladder, and Other Cancers (HCC 11) with a community, non-dual, aged base RAF weight of 0.307. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Anal canal cancer is distinct from rectal cancer and often has different etiologies (HPV association is common). Because C21.1 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C21.1 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Anal canal cancer is distinct from rectal cancer and often has different etiologies (HPV association is common)
- •Ensure documentation specifies anal canal location to distinguish from other anal structures
Clinical Significance
Malignant neoplasm of the anal canal is the most specific and common coding for anal cancer. The anal canal extends from the anorectal junction to the anal verge, and cancers here are predominantly squamous cell carcinomas with strong human papillomavirus association. The standard treatment is concurrent chemoradiation (5-fluorouracil and mitomycin C), with surgery reserved for treatment failure. This distinction from rectal adenocarcinoma is critical for appropriate treatment and risk adjustment.
Documentation Requirements
- ✓Documentation specifying anal canal as the tumor location
- ✓Histological type (squamous cell carcinoma vs adenocarcinoma vs other)
- ✓Human papillomavirus status and p16 immunohistochemistry results
- ✓Stage of disease including tumor size and lymph node status
- ✓Treatment approach (chemoradiation vs surgical)
Commonly Confused Codes
- •C20 — Rectum: tumors above the anorectal junction (dentate line) are rectal, not anal; treatment differs fundamentally
- •C21.0 — Anus, unspecified: use C21.1 when the canal is specifically documented
- •C21.2 — Cloacogenic zone: the transitional zone at the upper anal canal
- •C44.500 — Skin of perianal region: cancers of the perianal skin exterior to the anal verge are skin cancers, not anal canal cancers